| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0270-9139(95)90513-8 |
| P698 | PubMed publication ID | 7875662 |
| P2093 | author name string | Takano S | |
| Omata M | |||
| Tagawa M | |||
| Imazeki F | |||
| Yokosuka O | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic hepatitis B | Q55779876 |
| chronic hepatitis | Q62019625 | ||
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | 650-655 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients | |
| P478 | volume | 21 |
| Q81282931 | A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes |
| Q90198704 | APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation |
| Q38552131 | APASL consensus statements and management algorithms for hepatitis C virus infection. |
| Q89661742 | Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis |
| Q61451065 | Advances in genomic hepatocellular carcinoma research |
| Q36992263 | Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa |
| Q21144283 | An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load |
| Q80213158 | Anatomic wide hepatectomy for treatment of hepatocellular carcinoma |
| Q30479629 | Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma |
| Q40595308 | Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis |
| Q36590942 | Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan |
| Q36620680 | Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization |
| Q33391833 | Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma |
| Q45368558 | Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy |
| Q55005053 | Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis. |
| Q45036838 | Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma |
| Q45494522 | Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area |
| Q46967691 | Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience. |
| Q36178985 | Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas |
| Q26775804 | Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis |
| Q45730394 | Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients |
| Q42997162 | Correlation of clinicopathologic features of resected hepatocellular carcinoma with hepatitis C virus genotype |
| Q37356370 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus. |
| Q37340550 | Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer |
| Q37353679 | Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection |
| Q36496830 | Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy |
| Q43807771 | Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. |
| Q30384119 | Diagnostic Accuracy of Real-Time Shear Wave Elastography for Staging of Liver Fibrosis: A Meta-Analysis. |
| Q53407925 | Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. |
| Q44163692 | Dose-response trial of lactoferrin in patients with chronic hepatitis C. |
| Q43031528 | Dynamics of immature subsets of dendritic cells during antiviral therapy in HLA-A24-positive chronic hepatitis C patients |
| Q36431812 | Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study |
| Q43032055 | Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma |
| Q34225751 | Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma |
| Q37245488 | Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C |
| Q36950974 | Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis |
| Q41817486 | Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma |
| Q30422199 | Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. |
| Q34563350 | Epidemiology of primary and secondary liver cancers |
| Q45105371 | Factors contributing to ribavirin-induced anemia |
| Q79931452 | Fibrosis in non-cancerous tissue is the unique prognostic factor for primary hepatocellular carcinoma without hepatitis B or C viral infection |
| Q35010547 | Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients |
| Q45031715 | Hepatitis C knowledge among primary care residents: is our teaching adequate for the times? |
| Q56917098 | Hepatitis C virus and hepatocellular carcinoma |
| Q38309880 | Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability |
| Q41619963 | Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment |
| Q35360310 | Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. |
| Q60932814 | Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response |
| Q34134967 | Hepatocellular carcinoma in the world and the middle East |
| Q33866448 | Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations |
| Q36746503 | Hepatocellular carcinoma: management of an increasingly common problem |
| Q41667261 | Histopathology and pathobiology of hepatotropic virus-induced liver injury |
| Q52331305 | Identification and Screening of 416 Patients with Chronic Hepatitis at High Risk to Develop Hepatocellular Cancer |
| Q52584421 | Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. |
| Q45494455 | Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C. |
| Q35086429 | Impact of oestrogens on the progression of liver disease |
| Q43035805 | Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. |
| Q58100048 | Increased mortality after liver transplantation for hepatocellular carcinoma in hepatitis B-associated cirrhosis |
| Q42168851 | Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients |
| Q50795217 | Interferon therapy improves the irregular regeneration of hepatocytes in liver in patients with C-viral chronic hepatitis and liver cirrhosis. |
| Q45414516 | Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis |
| Q33988105 | Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C. |
| Q34225588 | Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma |
| Q33867509 | Mechanism of T cell hyporesponsiveness to HBcAg is associated with regulatory T cells in chronic hepatitis B |
| Q36179081 | Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer |
| Q27477952 | Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma |
| Q64080308 | Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review |
| Q57763653 | Natural Course of Small Nodular Lesions with Intranodular Preserved Portal Supply in Cirrhotic Liver |
| Q42999252 | Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C--a study of 527 patients at one establishment |
| Q35596530 | Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications |
| Q35668734 | Natural interferon-beta treatment for patients with chronic hepatitis C in Japan |
| Q35615742 | Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma |
| Q26853138 | New treatments for genotype 1 chronic hepatitis C - focus on simeprevir |
| Q45736775 | Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus |
| Q44259758 | Normalization of markedly elevated alpha-fetoprotein in a virologic nonresponder with HCV-related cirrhosis |
| Q36501509 | Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy |
| Q37845191 | Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a HuGE systematic review and meta-analysis |
| Q44503949 | Postoperative outcomes of patients with hepatocellular carcinoma negative for all virus-related markers |
| Q42991466 | Prediction of efficacy of interferon treatment of chronic hepatitis C and occurrence of HCC after interferon treatment by a new classification |
| Q45341300 | Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy |
| Q41859914 | Primary hepatic cancers with multiple pathologic features in a patient with hepatitis C: report of a case |
| Q43032321 | Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations |
| Q42996364 | Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score |
| Q35020896 | Progression from chronic hepatitis to hepatocellular carcinoma: natural course and treatments |
| Q51758507 | Protection of estrogens against the progression of chronic liver disease. |
| Q42123495 | Radiofrequency ablation of hepatocellular carcinoma in patients with and without cirrhosis |
| Q64115461 | Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment |
| Q36496627 | Relative predictive factors for hepatocellular carcinoma after HBeAg seroconversion in HBV infection |
| Q91872489 | Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis |
| Q50619400 | Risk factors and prevention of hepatocellular carcinoma in HCV infection. |
| Q42981929 | Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients |
| Q45164435 | Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy |
| Q26830794 | Risk factors for hepatocellular carcinoma in India |
| Q35010773 | Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C |
| Q79294727 | Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma |
| Q26823538 | Role of occult hepatitis B virus infection in chronic hepatitis C |
| Q38315152 | SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV. |
| Q37278194 | Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma. |
| Q47548449 | Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin. |
| Q30389962 | Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement |
| Q33888088 | Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma |
| Q73674282 | Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group |
| Q45415812 | Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival |
| Q43046673 | Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis |
| Q41514614 | Telomere, telomerase and digestive cancer |
| Q90399068 | Thalassemia and hepatocellular carcinoma: links and risks |
| Q36504707 | The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma |
| Q36011951 | Therapeutic modalities in hepatitis C: challenges and development |
| Q42995254 | Treatment of chronic hepatitis C with interferon alone or combined with ribavirin in Japan |
| Q39199815 | Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging |
| Q36814387 | Viral genotypes and associated risk factors of hepatocellular carcinoma in India |
| Q35791300 | cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis |
Search more.